Sanofi and Zentiva - Top 10 deals of 2008

Who: Sanofi-Aventis
With: Zentiva
What: $2.6B buyout

Summary: After making several bids for Czech generic drugmaker Zentiva, Sanofi-Aventis finally struck gold with a 1,150 Czech crowns-per-share bid of $2.6 billion. Sanofi is one of several Big Pharmas on this list to pay big bucks to beef up its generic capability, which will likely play an important roll in the drug industry in the years ahead.